Dec 16 - IBM (IBM.N) has agreed to settle a patent lawsuit against Zynga after it won a $45 million jury verdict against the mobile game maker earlier this year, according to a filing in Delaware
Author:Peiyu Liu, specialized in Intellectual Property field, especially in Patent, with Qualification of Chinese Attorney and Patent Attorney. SJD Candidate in Global Intellectual Property, MSc in
Context: French pharma giant Sanofi and its rival Amgen have been embroiled in patent infringement litigation over their respective cholesterol-lowering drugs, Praluent and Repatha, for over 10 years
In the pan-European dispute over Soliris, Alexion has now suffered another defeat. The UK High Court found that an important patent relating to the active ingredient eculizumab would have to be
sales in other countries, and there are no lawsuits against Sunwoda elsewhere. In Germany, Sunwoda filed nullity actions against EP 139 and EP 141. The Federal Patent Court’s preliminary opinion deemed
According to an order of the Düsseldorf local division, the parties have now settled (case ID: UPC_CFI_504/2023). The details of the settlement are not known. However, according to JUVE Patent sources
A long-running dispute between Fresenius Medical Care and Nipro over dialysis technology has concluded in Germany. The Federal Court of Justice declared the patent-in-suit invalid, thereby removing
at the Mannheim local division concerns EP 2 028 981, the patent-in-suit at the Paris local division is EP 3 155 936. Both relate to a juice extractor. In March, the Mannheim division found that NUC
EPO, and an infringement suit was dismissed by Munich Regional Court. Today, the Mannheim local division also dismissed the infringement suit relating to the second patent. Dish accuses Aylo of
The global patent dispute between Nokia and Amazon has ended. Today, the Finnish tech company announced it had signed an agreement with the US company covering the use of Nokia's video technologies